The U.S. Market for Over-the-Counter Pain Medication

   Single User - $3,000
   Corporate License - $6,000

Published Jan 1, 2005 | 306 Pages | Pub ID: KLI1023975

The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace.

The report provides a comprehensive analysis of the pain medication products that are currently in the market, as well as those likely to enter the market in future. The study focuses on the market movements and the factors that will fuel sustainable growth. The markets for these products range from the new and emerging, to the comparatively matured. Apart from the broad classification of external and internal analgesics, OTC pain medication products have been categorized into the following five generic groups for the purposes of this study:

  • Aspirin
  • Acetaminophen
  • Other NSAIDs (Ibuprofen, Ketoprofen & Naproxen)
  • Combination formulations
  • Topical analgesics (external analgesics)

Historical data are provided for 2000 through 2004. Compounded annual growth rates (CAGR) are provided for the periods 2000-2004, with forecast data from 2005 to 2009.

In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.